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Radio Frequency Identification Devices (RFID) technology is used by hospital supply 
chains to track various medical products and monitor inventories. To improve overall 
operations, hospitals have implemented RFID as part of their supply chain processes.  Hospitals 
have also have begun incorporating RFID technology as part of their transfusion services 
processes. The purpose of this review was to analyze how healthcare organization supply chains 
can benefit from the utilization of RFID systems in transfusion services departments. The 
methodology for this study was a literature review following the steps of a systematic review with 
a total of 51 sources referenced. 
RFID technology is being used to manage and track blood products from the initial 
donor phlebotomy to final disposition or product transfusion. Through RFID, transfusion 
departments and hospital supply chains have been able to manage blood samples and 
components to facilitate identification and transfusion of blood products to the correct patient. 
RFID-enabled transfusion practices have successfully increased provider productivity and 
product quality through work-reduction times and error reduction. A pilot study in one Iowa 
hospital system yielded a 3%-10% reduction in misidentification of patients and/or blood 
products during transfusion.   A cost-benefit assessment reported showed a 5-year ROI of 2%, 
with an approximate pay-back period of four years. Cost of RFID tags can be 10-15 times more 
expensive than barcode systems. There are also risks of this technology involving privacy and 
the security of patient information.    
Findings of this research study suggest that RFID has provided improvements in quality 
of care and efficiency, while initial costs, security and privacy appeared as principal barriers of 
adoption.   
 
Key Words: Supply Chain, Blood Bank, Transfusion Services, Radio Frequency Identification 




Supply Chain Management (SCM) in the healthcare setting is the practice of actively managing 
the material and information flow within an organization in order to provide the highest level of 
customer service to end-users, while also maintaining a competitive advantage in overall 
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business processes (Handfield, 2011). SCM within healthcare organizations entails the 
procurement of organizational products, data management, and logistics operations (Roark, 
2005). Additionally, SCM involves the accurate, day-to-day operations, and efficient movement 
of goods throughout an organization (Handfield, 2011).  
 
In maintaining and improving the SCM’s operation processes, hospitals have begun to 
incorporate Radio Frequency Identification Device (RFID) technology to control, monitor, and 
evaluate products and goods throughout the organization. RFID technology systems utilize radio 
frequency electromagnetic fields to obtain data for tracking and identifying medical products and 
goods (RFID Journal, 2012a). RFIDs contain identification tags that enable a scanning a device 
(reader) so contents, location, manufactured date, order numbers, batch numbers, dosage 
information and shipping data can be transmitted to a corresponding data terminal (HDMA, 
2004). In healthcare organizations, tags have been placed on patients, pharmaceuticals, mobile 
assets, and blood products.  These items can be scanned with RFID reader software and tracked 
by potential end-users (Yao, Chu, & Li, 2012). RFID technology has allowed for increased 
efficiency of employees and management of product volumes stored within the healthcare 
facility (The Institution of Engineering and Technology, 2009).  
 
RFID technology has slowly integrated into healthcare settings due to a lack of 
immediate payback in savings, and with continuous advancement, many providers do not want to 
invest in implementing and managing the technology (The United Postal Service, 2005). Even 
though there has been slow integration, several areas within health care organizations have 
started utilizing RFID technology. An example of RFID implementation is the process of 
identifying, tracking, and monitoring the status of blood products from the point of collection to 
the final disposition, or transfusion, of the product to patients (Kozma, Speletz, Reiter, Lanzer, & 
Wagner, 2011). Through RFID, transfusion departments and supply chains are able to manage 
blood components to facilitate the delivery of correct blood products to the correct patient 
(Sandler, Langeberg, Carty, & Dognalek, 2006). According to these authors, RFID enabled 
transfusion processes can become more efficient by simplifying verification processes.  
 
As RFID technology has been implemented in patient care areas, safety concerns exist 
due to emission of low radiation levels from the devices. While there have not been reports of 
patient injury, there is a possibility these devices can have adverse reactions for patients with 
pacemakers or implantable cardiovascular defibrillators (FDA, 2012). As a measure of 
maintaining patient safety standards, continuous testing has assessed how these devices affect 
patients (FDA, 2012). Conversely, studies have shown that blood products exposed to the 13.56 
MHz radio waves an RFID emits has not shown significant adverse effects to red blood cells up 
to the 25th day of holding blood products (Kozma et al, 2011). These authors concluded that 





The purpose of this research was to analyze how healthcare organization supply chains 






The approach for this research review followed an organized search pattern adapted from the 
conceptual framework of Yao, Chao-Hsien and Li (2010).  The use of this conceptual framework 
in the current study is appropriate because the focus of both studies is to show how new 
technologies (RFID) can be applied to healthcare settings (Blood banks) to enhance the care of 
patients, as well as this approach has been successfully replicated in previous studies, increasing 
its internal validity (Coustasse, Tomblin, Slack 2013; Deslich, Coustasse 2014).  This framework 
was utilized to allow clear identification of the benefits of RFID and barriers to implementation 
of RFID in transfusion medicine.  To research problems involving the current processes in 
transfusion medicine, it was first necessary to recognize the existing problems and issues that 
drive and impede adoption of RFID with regards to blood component processing and transfusion.  
Figure 1 illustrates the progression to implementation of RFID in transfusion services and 
identifies the recognition of both benefits and barriers to adoption.   
Problems in the 
Blood Bank 
Supply Chain






1. Conceptual Framework, Yao, Chu & Li (2010) 
The methodology utilized in this literature review conformed to the principles of a systematic 
search. For the intent of this research query, a comprehensive and exhaustive review was not 
feasible due to the abundance of studies of heterogeneous quality. The literature review was 
conducted in three distinct stages including the following: 1) determining the search strategy and 
literature Identification and collection, 2) establishing inclusion criteria, scrutinizing text for 
relevancy, and literature analysis of the data, and 3) identification of appropriate categories.  
 
Step 1: Literature Identification and Collection 
 
 The electronic databases of PubMed, Science Direct, EBSCOhost, ProQuest, Science 
Direct, Academic Search Premier and Google Scholar were searched for the terms ‘RFID’ AND 
‘supply chain’ AND ‘blood bank’ OR ‘transfusion services’ OR ‘benefits’ OR ‘barriers’. The 
 3 
International Journal of Blood Transfusion Medicine, The International Journal of Medical 
Informatics, The Journal of Health Information Management, and other reliable healthcare 
websites, including those of the College of American Pathologists, Food and Drug 
Administration, Red Cross and the American Association of Blood Banks, were also used. 
Citations and abstracts identified by the search were also assessed in order to identify relevant 
articles. 
 
Step 2: Establishing inclusion criteria and Literature Analysis 
 
Given the technology- and enterprise-oriented nature of the current study, literature was 
selected following technological and organizational impacts of use of RFID. The search was 
limited to sources published in the last 11 years (since 2003) to attempt to stay current in the 
research study. The search was also limited to sources attainable as full texts, and those written 
in the English language. The methodology and results of the identified texts were analyzed and 
key papers were identified and included within the research query. References were reviewed 
and determined to have satisfied the inclusion criteria if the material provided accurate 
information about RFID in blood banks with a particular focus on benefits and barriers to its 
implementation. From a total of 94 references found a total of 51 references were selected for 
this research study. The literature search was conducted by BC, PM, and SD and validated by 
AC, who acted as second reader and also double checked if references met the research study 
inclusion criteria. 
 
Step 3: Literature Categorization 
 
 The results were structured following the conceptual framework and employed the use of 
sub-headings including: Background of RFID in Healthcare Organizations, Use of RFID in 
Transfusion Medicine, Benefits of RFID in Transfusion Medicine, and Barriers of RFID 




Background of RFID in Health Care Organizations  
 
Efficient SCM systems within healthcare organizations are an important aspect when 
providing the best patient care, while containing operating costs. RFID technology has become a 
$2.1 billion industry so assessing which inventory management system to use is imperative for a 
particular healthcare organization’s effectiveness (Tu, Zhou, & Piramuthu, 2009). Through RFID 
systems, medical product data entry is fast, automated, and contactless via radio waves (Singh, 
Kumar, Kaur, & Aboul-Enein, 2008). As a result, goods can be moved faster and cheaper while 
being tracked in a more accurate and timely fashion (Lapide, 2004). Implementing RFIDs in 
hospital supply chains has allowed healthcare organizations to operate more efficiently, improve 
organizational quality, and increase patient-level accessibility (Revere, Black, & Zalila, 2010). 
 
 The two key components of RFID systems include tags and readers (Schwaitzberg, 
2006). Tags consist of silicon microchips and antennas that receive or emit radio frequencies 
depending on whether the tag is active or passive (Schwaitzberg, 2006). Passive tags, costing 
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between $0.10 and $.50 per tag, lack a power source, generally store less than 2 kilobytes of data, 
and are primarily used in short-range situations where tag reading is not important (Kumar, 
Livermont, & McKewan, 2010). Active tags possess an internal power source and continuously 
transmit and receive signals further than 3 meters. Active tags, which cost between $.50 and $50 
per tag, are able to store between 2 kilobytes and 128 kilobytes of data and are used in medium-
distance and expensive situations where fast reading is needed. (Kumar et al, 2010). 
 
 As RFIDs have become more prevalent in United States (U.S.) industries, the processes 
to utilize these systems have also grown. In June 2003, Wal-Mart required that their top 100 
suppliers to place RFID tags on each of their pallets and item cases by January 2005 (Lapide, 
2004). As a result, more than 300 suppliers currently feed RFID-tagged goods to 500 Wal-Mart 
facilities (Songini, 2006). Additionally, The U.S. Department of Defense (DoD) began enforcing 
new policies in which all government vendors would be required to use RFID passive tag 
technology when shipping pallets and cases to the DoD’s inventories throughout the country by 
January 2005 (Brewin, 2003). The required policy allowed for the DoD to track over 45 million 
line items from each of their 43,000 different suppliers (Erickson & Kelly, 2007). Policies such 
as these have provided other industries throughout the U.S. a foundation on which to base their 
RFID utilization practices.   
 
Using RFID-enabled medical assets in inventory management and product tracking 
throughout hospitals has become an important part of providing patient care in a timely and 
effective manner (Tu, Zhou, & Piramutho, 2009). It has been estimated that a typical hospital is 
unable to locate about 15%-20% of its assets, which can lead to increased purchasing, increased 
expenditures, and lack of control throughout the network (Tu et al., 2009). In placing RFIDs on 
medical assets, employees can use RFID software to locate devices needed for patient care 
throughout the hospital by searching their location, the RFID can transmit to the user its specific 
information about location and product, and use can be monitored accurately (Oztekin, Pajouh, 
Delen, & Swin, 2010). 
 
Use of RFID in Transfusion Medicine 
 
 In providing transfusion services to patients, there is a multi-step process of transferring 
blood products from donation or supply centers to medical facilities. Over 15.7 million blood 
donations are collected each year and approximately 30 million transfusions are performed 
yearly in the United States (ARC, 2014).  The primary steps involved in the transfer of blood 
products are identification, screening, and labeling (Goodnough et al, 2009). According to Dzik 
(2006), the root causes of transfusion errors occur in the stages of correct identification of the 
blood drawn at the time of donation, the correct identification of the intended recipient at the 
bedside, errors in laboratory testing and screening, and error in labeling of blood samples. 
Goodnough et al (2009) claimed that human error is accountable for these errors and suggested 
that electronic technologies, such as RFID, can reduce the errors associated with blood ordering 
and patient/specimen identification. In a study of RFID implementation in multiple blood 
centers, Davis, Geiger, Gutierrez, Heaser, & Veeramani (2009) concluded that RFID-enabled 
transfusion practices were successfully performed and increased provider productivity and 
product quality.  
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Transfusion medicine is in the beginning stages of adopting RFID technology to support 
blood collection, as well as the processing, labeling, inventory, and distribution of blood 
products (Ralf et al, 2010). According to these authors, RFID has been used to regulate and 
monitor smaller samples of red cells, plasma, platelets, and other blood-related products. In the 
process of tracking blood samples, the blood bag and the containers used for product transport 
are enabled with an RFID tag to monitor the precise location of the blood product and to account 
for missing and unused samples (Briggs et al., 2009). A packing slip is included in the transport 
container and contents are verified by the receiving blood center or healthcare facility 
(Hohberger, Davis, Briggs, Gutierrez, & Veeraman, 2012). Once the tagged products arrive, are 
received in by an RFID enabled database at the receiving facility (Hohberger et al, 2012). In the 
event of medical emergencies, such as trauma patients with severe blood loss, blood donation 
and processing centers and hospital transfusion services departments are able to utilize RFID to 
locate and track the closest available compatible blood products to treat these patients (Boulos & 
Berry, 2012). 
 
As medical error-related deaths continue to rise, it has been made a priority by the 
Institute of Medicine to find ways to reduce the number of these deaths (Ralf et al, 2010).  In 
2013, preventable medical errors accounted for an estimated 210,000 to 400,000 deaths per year 
(James, 2013). Throughout transfusion-related services, human errors are bound to occur due 
high patient volumes and other external factors (Davis et al, 2009). Integrating RFID systems 
into transfusion supply chains allows for the opportunity to provide safer transfusions and 
improve the quality of blood products (Ralf et al, 2010). According to Briggs et al (2009), RFID 
has been able to reduce prevalence of morbidity and mortality of patients receiving transfusions. 
RFID utilization in transfusion services will be able to improve transfusion medicine workflow 
processes through increased productivity, positive patient outcomes, and significant cost savings 
(Ralf et al, 2010). 
 
Progress has been made toward the adoption of RFID in recent years.  The Transfusion 
Medicine RFID Consortium was formed to research the use of RFID methods and devices to 
identify and track blood products from the point of collection and distribution to final disposition 
or transfusion.  The consortium included representation from blood collection and processing 
facilities, hospitals, RFID industry consultation from middleware and information system 
companies (Transfusion Medicine RFID Consortium, 2012).  In May 2013, the Food and Drug 
Administration approved the use of iTrace, a RFID device, to store and track the manufacturing 
data of blood products including the collection, processing, and labeling of components (FDA, 
2013). 
 
Benefits of RFID in Transfusion Medicine 
 
As part of implementing RFID technology in transfusion services, the Massachusetts 
General Hospital has taken the opportunity to utilize this technology in order to prevent blood 
transfusion errors (Vasu, 2012). First, the patient is assigned an identification number in the form 
of an RFID-enabled wristband, which is used to track all patient information throughout the 
entire transfusion process. The patient is then taken to the treatment area where an RFID enabled 
mobile point-of-care trolley initially verifies the patient’s identity and procedure to be 
performed. Staff members then scan the patient’s wristband into the RFID blood data system and 
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once the transfusion is complete, the staff member scans the tagged blood bag into data system 
once again to complete the process (Vasu, 2012). A similar RFID transfusion system 
implemented in four Italian hospitals during a 2008 pilot study has shown significant 
improvement in work-reduction times and error reduction by 100% (RFID Journal, 2012b). The 
goal of this study was to record data in order to improve upon future systems and processes to 
achieve perfection (RFID Journal, 2012b). 
 
The use of RFID technology in hospital supply chains can provide multiple benefits to a 
healthcare organization’s business operations. RFIDs can increase patient safety, speed critical 
treatments, reduce supply chain costs, and provide better tracking of patient drug-treatment 
compliance, which leads to better follow-up treatment. Benefits of using RFIDs in hospitals not 
only include improved supply chain efficiency, but also translate into saving lives or improving 
patient outcomes (Wicks, Visich, & Li, 2006).  
 
As outlined in Table 1, the benefits of utilizing RFID systems in Transfusion Medicine 
have ranged from improved identification of patients and blood components to long-term savings 
and increased productivity.  A cost-benefit assessment examined by Davis et al. (2009), showed 
a 5-year ROI of 2%, with an approximate pay-back period of 4 years. (Table 1)  From a patient 
safety standpoint, RFID implementation has also been proven as a valid and logical method of 
increasing positive patient outcomes.  Lou et al. (2011) reported that passive RFID allows for 
increased positive identification of recipients, and thereby a decrease in fatal transfusion 
reactions.  As shown in Table 1, Porcella and Walker (2005) described that a pilot study in one 
Iowa hospital system yielded a 3%-10% reduction in misidentification of patients and/or blood 
products during transfusion.  In addition, the Transfusion Medicine RFID Consortium (2012) 
noted a 33% reduction in misidentification in addition to total elimination of delivery errors and 
an 87% reduction in product loss. (Table 1) 
 
Barriers of RFID Adoption in Transfusion Medicine 
 
Although RFIDs offer healthcare facilities an opportunity to increase productivity, 
efficiency, and produce higher quality care and safety standards, there are risks involving privacy 
and the security of patient information. In utilizing lower quality tags, there is an increased 
probability that patient information can be accessed by unauthorized sources (Lockton & 
Rosenberg, 2005). Through such uses of low-quality RFID technology, the privacy and 
anonymity of patients is susceptible to violations regarding the Health Insurance Portability and 
Accountability Act (HIPAA) (Rieback, Gaydadjiev, Crispo, Hofman, & Tanenbaum, 2006). 
Tags do not possess the ability to verify if readers have permission to access the chosen 
information, which in turn, jeopardizes the tag’s programmed ID, Protected Health Information 
(PHI), including patient preferences and behaviors, as well as, confidential health records 
(Rieback et al, 2006). This information can fall victim to eavesdropping if not properly protected 
through proper high-quality RFID tag systems.  
 
While the benefits of RFID implementation in transfusion service management are 
numerous, there are barriers that hinder adoption as denoted in Table 2.  Yao et al. (2010) 
examined the startup costs of RFID implementation in an 800 bed hospital found that initial 
investment can range from $20,000 to $1 million, depending on the magnitude of 
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implementation and desired usage. Also according to the College of American Pathology, in 
2005 the cost of RFID tags was 10-15 times more expensive than barcode systems (Table 2). 
Perhaps one of the most significant barriers to RFID utilization is the issue of patient 
confidentiality as identified by Jules (2006) and Lahtela (2009). In a session conducted at the 
2011 Annual Meeting of the American Association of Blood Banks, concerns of RFID safety 
and morphological and biochemical effects on blood components were discussed. (Table 2) 
 
Solutions to security and privacy issues in RFID technology involve de-activating or 
killing a tag after a patient is discharged from a facility, which prevents the tag from being 
interoperable with any systems after that point (Ngai, Moon, Riggins, & Yi, 2008). A Hash-Lock 
approach can be used so that PHI can only be accessed when a password or key is entered to 
verify that the reader has access to the designated tag information (Weis, 2003). Silent tree 
walking can also be utilized, which prevents eavesdropping from unauthorized readers to hear a 
signal sent to a tag from a designated reader, blocks the unauthorized reader from hearing the 
signal that is sent from the tag back to the designated reader (Weis, 2003). Security of RFID-





RFID technology is not considered to be a new technology, but it is new in terms of integrating 
this technology into health-related practices. The skepticism leaders in U.S. healthcare feel 
towards RFID has reflected upon the low adoption levels. As RFID technology has continued to 
develop and emerge as a practical way to efficiently manage goods, organizations and 
government agencies, such as Wal-Mart and the DoD, have required their top suppliers to utilize 
RFID. Wal-Mart’s and the DoD’s mandates have lead the way in developing SCM RFID system 
models for other industries. Wal-Mart’s and the DoD’s efforts in mandating RFID technology as 
part of their SCM operations has led to other industries following in their tracks, but healthcare 
organizations are still lagging behind (Songini, 2006). It appears that the majority of healthcare 
organizations have been hesitant to adopt RFID technology as part of their SCM operations due 
to high start-up and maintenance costs, interoperability issues, and data security standards. 
 
  RFID possesses several positive qualities in terms of patient care and employee 
efficiency. RFID has allowed healthcare organizations to gain access to accurate and timely PHI 
in order to treat patients efficiently and effectively. RFID has permitted transfusion service 
professionals to accurately draw blood from a donor, perform tests on blood samples, and 
quickly return lab results to treating physicians.  RFID can aid in the reduction of clerical errors 
involving pre-transfusion testing and positive patient identification.  The more efficient tracking 
mechanisms provided by RFID systems, allows for ease of inventory management and reduces 
product out-dating, as processing centers can monitor hospital inventories and transfer short-date 
products to a facility where the products are more likely to be utilized prior to expiration.  The 
ability to readily track component availability can increase positive patient outcomes in 
situations requiring emergency release of blood products by streamlining inventories and transfer 
of products between facilities.  RFID systems also make it easier to perform “lookbacks” when 
the final disposition information for a blood product is required due to component, processing, or 
donation issues that arise either prior to or after transfusion. Additionally, the chances of blood 
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being lost within or between organizations are significantly reduced. As a result, patients are 
treated quickly, accurately, and effectively to reduce the amount of wasted, or unnecessary, 
treatment. 
 
 In the past decade, healthcare organizations have begun to implement RFID technology 
as part of improving their overall transfusion service processes. In utilizing RFID systems, the 
tags are placed on blood products after going through the identification verification processes 
beginning at the initial phlebotomy or donation, and ending with the transfusion of that product 
to a compatible recipient.  The primary purpose of implementing RFID as part of providing 
transfusion services was to increase the provider’s work efficiency, and most importantly, 
improve patient outcomes. The majority of research regarding RFID implementation in 
transfusion medicine has suggested that the positive implications outweigh the negative 
implications, and therefore, should be adopted by healthcare organizations. 
 
 One of the most significant benefits of utilizing RFID in transfusion services is the 
impact on positive patient identification by aiding in the elimination of human error.  By utilizing 
RFID to identify recipients, the risk of misidentification of blood products and patients is 
significantly decreased. It is possible that many incidents of misidentification go undetected 
during transfusions, if the products transfused are inadvertently compatible with the recipient.  
RFID would make it possible to better track product and patient information and to ensure such 
incidents do not occur. 
 
The two major negative implications of RFID systems account for in healthcare 
organizations are the privacy of PHI and system implementation. Once medical products 
encrypted with patient data become RFID-enabled, the data associated with that product is 
susceptible to privacy and accessibility issues. Though RFID tags are capable of being secured 
with passwords and access codes to protect encrypted data, the cost of doing so comes at the 
organization’s expense. The expense of ensuring that patient privacy is maintained at the highest 
level is a major concern for healthcare organizations attempting to control costs.  
 
In addition to the cost of maintaining PHI privacy, the costs of implementing, operating, 
and maintaining RFID systems can be significant. RFID systems in healthcare organization 
supply chains can become extremely complex to the point that healthcare organizations believe 
that it would not be considered a feasible technology to adopt within their organization. In order 
for a healthcare organization to realize the positive effects of a fully implemented RFID system, 
healthcare organizations must be willing to invest a significant amount of resources towards the 
implementation and maintenance of the RFID system. 
 
This study was limited due to the restrictions in the search strategy used, such as the key 
terms searched, while researcher and publication bias may have limited the availability and 
quality of the research identified for review. 
 
 RFID technology in the U.S. healthcare industry could potentially change the way health 
services are delivered for years to come. The lack of control of healthcare costs in the U.S. 
continues to be a growing concern and this reviews suggest that utilizing RFID systems in the 
U.S. healthcare system may be a way to control health care expenditures. The adoption of RFID 
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systems in transfusion services may only appear to be a small solution to a major problem, but 
one that could change the way health care is delivered.  There is still much more research that 
needs to be done in order to evaluate whether the implementation of RFID technology in 




The implementation of RFID in transfusion medicine offers many benefits over current 
procedures utilized in the tracking of blood products from the time of donation to transfusion or 
final disposition.  RFID technology is not without risks, with specific concern noted regarding 
security and patient confidentiality, as well as high implementation costs involved with RFID 
systems.  Further research, the benefits of RFID are anticipated to lead to wide-spread utilization 
in transfusion medicine.  As RFID gains acceptance in the field of blood banking, significant 
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Table 1: Benefits of Implementation and Utilization of RFID Systems in Transfusion 
Medicine 
SOURCE BENEFITS 
College of American Pathologists, 
2005 
• RFID allows for accurate identification of blood products and 
recipients. 
• RFID tags eliminate transfusion error due to patient 
misidentification. 
Porcella & Walker, 2005 • Pre and posttest of RFID in transfusion medicine, first in a 
pilot of 5 units in an Iowa hospital system, then in a system 
wide implementation. 
• In pilot, rate of detection of misidentified patients or blood 
products increased between 3% and 10%, and in the system 
wide implementation, the rate increased 30%. 
Chang & Huang, 2008 • Pre and posttest of RFID implementation in a blood center. 
• Detection of misidentified blood products improved 19%. 
Davis et al., 2009 • Literature review of comprehensive assessment with a cost-
benefit model. 
• Found a 2% ROI over a 5-year planning horizon with an 
approximate 4-year pay-back period. 
Kumar, 2009 • Pilot Study of RFID implementation and utilization. 
• Found an inventory savings of $150,000 through the pilot 
program. 
Revere et al., 2010 • Overview of hospitals that have instituted RFID within their 
organization. 
• North Carolina hospital Wayne Memorial reported a savings 
of more than $300,000 due to RFID initiatives. 
Lou et al., 2011 • Passive RFID tags decrease fatal blood transfusions by linking 
all specimens and procedures during hospitalization. 
• Higher data storage than barcodes. 
• Temperature sensing potential important in component 
storage. 
Pustkova et al., 2011 • Examination of implementation of RFID to assist with visual 
examination and identification of blood specimens in a single 
hospital setting. 
• Increased job performance in transfusion medicine processes. 
Poshywak, 2012 • Examination of implementation and realization from facilities 
who have already implemented new technology. 
• Return on investment showed the annual impact, on a 5 year 
projection, of more than $10 million. 
Transfusion Medicine RFID 
Consortium, 2012 
• Pilot study of RFID implementation and utilization in a blood 
donation center and hospital setting. 
• Reduced donation site misidentification and lost products by 
33%, reduced final destination loss of product by 87%, 
increased efficiency by 63%, had zero delivery errors. 
Hohberger  et al., 2013 
 
• Pre and posttest of RFID implementation in a large 700 bed 
academic hospital emergency room and blood and marrow 
transplant units. 
• Found the system payback period to be 2-5 years, and an 
increase in employee performance of 10% with the 
implementation and utilization of RFID. 
Kotzen, 2013 • Review of Virtua Health Systems implementation of RTLS, 
saving an estimated $1.2 million through error prevention and 
employee job performance. 
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Table 2: Barriers of Implementation and Utilization of RFID Systems in Transfusion 
Medicine 
SOURCE BARRIERS 
College of American Pathologists, 
2005 
• Cost of RFID tags can be 10-15 times more expensive than 
barcode systems 
Juels, 2006 • Literature review that identified threats to security as rogue 
scanning, “eavesdropping” on either tag to scanner or scanner 
to tag communications. 
Chao et al., 2007 • Literature review that identified barriers to RFID use as cost 
to implement and security concerns. 
Lahtela, 2009 • Review of the structure and infrastructure of several RFID 
systems. 
• Threat to patient level data security was identified as a risk. 
 Yao et al., 2010 
 
• Examine of cost to implement RFID in an 800 bed hospital. 
• Found the startup contribution to be from $20 k to $1 million 
with $1,050 per day in medication tagging. 
American Association of Blood 
Banks, 2011 
• Safety issues of using RFID. 
• Studies required to test RFID tag ability to survive 
centrifugation, freezing and gamma radiation procedures 
involved in processing and storage of blood components. 
• Possible morphological and biochemical effects of RFID tags 
on blood components. 
Lou et al., 2011 • Additional costs involved with RFID system implementation 
include readers, middleware and software applications. 
• RFID readers can cost between $50-$3,000 each. 
• Software applications can range in cost from $25,000 to over 














Alberto Coustasse, DrPH, MD, MBA, MPH – CONTACT AUTHOR 
Associate Professor, Health Care Administration Program 
College of Business, Marshall University Graduate College 
100 Angus E. Peyton Drive 
South Charleston, WV  25303 
(304) 746-1968, (304) 746-2063 FAX 
coustassehen@marshall.edu 
 
Brian Cunningham, MS, Alumni 
Health Care Administration Program 
College of Business, Marshall University Graduate College 
 
Stacie Deslich, M.A., M.S., Alumni 
Health Care Administration Program 
College of Business, Marshall University 
 
Eric Willson, MBA, MS 
College of Business, Marshall University 
 
Pamela Meadows, MS, BSMT (ASCP) 
Assistant Professor-Clinical Laboratory Sciences 
College of Health Professions, Marshall University 
One John Marshall Drive 
Huntington, WV 25755 
(304)696-6596 
meadow63@marshall.edu   
 
 16 
